OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

5:50am IST
Change (% chg)

¥-2 (-0.93%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

OncoTherapy Science receives patent in Japan
Thursday, 13 Jul 2017 

July 13 (Reuters) - OncoTherapy Science Inc <4564.T>:* Says it received a patent (No.6159948 )for MELK specific inhibitors in Japan.  Full Article

OncoTherapy Science says first-patient enrollment in Phase I/II clinical study of OTS167
Friday, 15 Jul 2016 

OncoTherapy Science Inc <4564.T>:Says the first patient has been enrolled in Phase I/II clinical study of OTS167, an MELK-specific inhibitor, for Acute Myeloid Leukemia.  Full Article

OncoTherapy Science gets patent license
Monday, 16 May 2016 

OncoTherapy Science Inc <4564.T>: Says received a patent license in China .Says the patent is for specific inhibitor of TOPK (T-LAK cell-originated protein kinase), which being developed as an anti-cancer agent.  Full Article

BRIEF-OncoTherapy Science unit says joint development with Japanese Foundation For Cancer Research

* Says co's unit Cancer Precision Medicine signs joint development agreement with Japanese Foundation For Cancer Research